Figure 3From: OvMark: a user-friendly system for the identification of prognostic biomarkers in publically available ovarian cancer gene expression datasetsPrognostic role of SNAI3, PCDP1 and SERPINA2 in ovarian cancer. In each plot black denotes high expression of the marker(s) and grey denotes low expression. (a) Kaplan-Meier estimates of OS, demonstrating high expression of SNAI3 to be a marker of good prognosis in ovarian cancer (n = 827, HR = 0.61, p = 5.73 x 10−5). (b) Kaplan-Meier estimate of OS demonstrating that ovarian cancer samples with high expression of both PCDP1 and SNAI3 are associated with a better prognosis than ovarian cancers with high expression of either marker on its own (n = 827, HR = 0.46, p = 2.13 x 10−5). (c) Combing PCDP1, SNAI3 and SERPINA2 gives an even lower HR (HR = 0.42, p-value = 1.29 x 10−3, n = 827).Back to article page